Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1984 Jun;60(3):161–163. doi: 10.1136/sti.60.3.161

Two dose Augmentin treatment of acute gonorrhoea in men.

K B Lim, V S Rajan, Y C Giam, E O Lui, E H Sng, K L Yeo
PMCID: PMC1046291  PMID: 6428699

Abstract

We studied 192 men with acute gonococcal urethritis, 97 of whom received two oral doses of Augmentin (amoxycillin 3 g and clavulanic acid 250 mg) separated by a four hour interval; the remaining 95 received 2 g kanamycin in a single intramuscular injection. Of the patients treated with Augmentin, 93 (95.9%) were cured, which was significantly more than the 83 (87.4%) patients treated with kanamycin. Augmentin was equally effective in the treatment of penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG infections, the cure rates for which were 96.6% and 95.6% respectively.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashford W. A., Golash R. G., Hemming V. G. Penicillinase-producing Neisseria gonorrhoeae. Lancet. 1976 Sep 25;2(7987):657–658. doi: 10.1016/s0140-6736(76)92467-3. [DOI] [PubMed] [Google Scholar]
  2. Miller J. M., Baker C. N., Thornsberry C. Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate. Antimicrob Agents Chemother. 1978 Nov;14(5):794–796. doi: 10.1128/aac.14.5.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Perine P. L., Morton R. S., Piot P., Siegel M. S., Antal G. M. Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):152–158. doi: 10.1097/00007435-197904000-00021. [DOI] [PubMed] [Google Scholar]
  4. Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet. 1976 Sep 25;2(7987):656–657. doi: 10.1016/s0140-6736(76)92466-1. [DOI] [PubMed] [Google Scholar]
  5. Piot P., van Dyck E., Colaert J., Ursi J. P., Bosmans E., Meheus A. Antibiotic susceptibility of Neisseria gonorrhoeae strains from Europe and Africa. Antimicrob Agents Chemother. 1979 Apr;15(4):535–539. doi: 10.1128/aac.15.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rajan V. S., Leong Y. O. Spectinomycin dihydrochloride treatment of gonorrhoea. Singapore Med J. 1972 Jun;13(3):161–162. [PubMed] [Google Scholar]
  7. Rajan V. S., Sng E. H., Pang R., Tan N. J., Thirumoorthy T., Yeo K. L. HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae. Br J Vener Dis. 1980 Aug;56(4):255–258. doi: 10.1136/sti.56.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sng E. H., Rajan V. S., Pang R., Yeo K. L. Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime. Br J Vener Dis. 1981 Jun;57(3):162–164. doi: 10.1136/sti.57.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sng E. H., Yeo K. L., Rajan V. S. Simple method for detecting penicillinase-producing Neisseria gonorrhoeae and Staphylococcus aureus. Br J Vener Dis. 1981 Apr;57(2):141–142. doi: 10.1136/sti.57.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES